- Home
- News
- us virgislands
- catheter delivery
Catheter Delivery Articles & Analysis
22 news found
Among the various materials used in medical device design, polytetrafluoroethylene (PTFE tubing) has emerged as a standout choice, particularly in applications such as catheters and drug delivery systems. This article explores the role of advanced materials like these in driving innovation in medical devices, focusing on their benefits and implications for the ...
Next came Ocular Therapeutix Inc., to develop an absorbable punctal plug for the extended delivery of drugs to the surface of the eye. Augmenix Inc., now part of Boston Scientific Corp. ...
The difference between these two similar terms is that the block is a one-time application of painkiller via needle, while the epidural permits continued applications via a catheter. Complex birth situations: A delivery that is happening very quickly, or one that requires forceps to help the baby along—these are just a few examples. ...
The XFLO Expander System is designed to provide patients with immediate relief BPH-related symptoms (LUTS) by placing an expander implant in the prostatic urethra using a low-profile delivery catheter and a standard flexible cystoscope. The XFLO Expander System opens the prostatic urethra that is narrowed due to the enlargement of the prostatic lobes. ...
“Leonhardt’s Launchpads accelerator pursues innovations in bioelectrics, biologics, and endovascular delivery systems that have the potential to improve patient treatment options and outcomes significantly. ...
“Our vision for the future of this new energy source is to deliver it via a force sensing focal point ablation catheter and to guide that delivery with advanced 3D cardiac mapping, rather than fluoroscopy. ...
Business Development In April 2021, the Company entered into an agreement with a Japanese therapeutic partner related to the Helix biotherapeutic delivery product candidates. Under the terms of the agreement, BioCardia received $500,000, a portion of which is creditable for biotherapeutic delivery products and support services. The agreement has a one-year ...
The JenaValve Trilogy System consists of a Transcatheter Heart Valve and Transfemoral Delivery System. The bioprosthesis comprises a self-expanding nitinol stent with a porcine pericardial tissue valve manufactured using state-of-the-art tissue processing techniques. The transfemoral delivery catheter is designed to deliver the bioprosthesis ...
Moray Medical is developing a robotic catheter that makes delivery of therapies inside the beating heart as easy as moving a cursor on a computer screen. ...
Second Heart Assist has developed both a catheter-based and a wireless-powered chronic implant circulatory assist device. ...
During those years we developed intervascular lung catheter, a radiation delivery catheter, and we patented the first stem cell delivery catheter, PROCELL, that we designed to deliver stem cells to damage heart tissue. ...
An esteemed panel of subject matter experts, clinicians, and investors selected Moray Medical (then called Project Moray) as a Rosenman Innovator for its innovative technology and patient impact, digitizing the user interface of cardiac catheter systems to enable precise delivery of therapies within the beating hearts of millions of patients. ...
This is the first and only FDA cleared product made from solubilized silk protein and is expected to significantly impact the treatment of this condition due to the unique material properties of silk protein scaffold and a proprietary single-use catheter delivery system. “The clearance of Silk Voice for Vocal Fold Medialization is an important milestone ...
Colibri’s proprietary TAVI system features a replacement heart valve pre-mounted and pre-crimped on a balloon delivery catheter, pre-loaded into a low-profile access sheath and sterilized, ready-for-use from package to patient. ...
This proprietary TAVI system features a replacement heart valve pre-mounted and pre-crimped on a balloon delivery catheter, pre-loaded into a low-profile access sheath and sterilized, ready-for-use from package to patient. ...
As with Colibri’s earlier generation system, this TAVI system contains a replacement aortic heart valve that is pre-mounted, and pre-crimped on a balloon delivery catheter, loaded into a low-profile access sheath and sterilized, ready-for-use from package to patient. ...
Heartcel, Celixir’s lead investigational cardiac regenerative medicine, is a tissue engineered medicine comprising allogeneic (off-the-shelf) immunomodulatory progenitor (iMP) cells and is designated as an advanced therapeutic medicinal product (ATMP) by the European Medicines Agency. iMP cells are a novel cell type engineered to reduce heart scarring and regenerate the heart in patients ...
Colibri Heart Valve, LLC, a privately held medical device company, has been granted yet another patent directed to prosthetic heart valves. More particularly, today the U.S. Patent & Trademark Office granted Colibri U.S. Patent No. 8,361,144 entitled, “Percutaneously Deliverable Heart Valve Device And Methods Associated Therewith.” The patent is directed to a method of making a ...
Infuseon Therapeutics’ novel central nervous system deliver device has received FDA 510(k) clearance as a therapeutic delivery device. Infuseon Therapeutics’ Cleveland Multiport CatheterTM (CMC), a multiport convection-enhanced delivery catheter, was designed by neurosurgeon Michael Vogelbaum, MD, PhD, from Cleveland Clinic’s ...
” A crimped and loaded heart valve on a delivery catheter which is pre-packaged and ready-for-use, provides significant time, cost and safety benefits associated with a transcatheter heart valve replacement procedure. ...